Integrative Network Pharmacology and Transcriptomic Analysis Identifies Candidate Targets of Carthami Flos in Ulcerative Colitis

Background: Carthami Flos contains diverse phytochemical constituents with reported biological activities, but the potential relationships between its predicted molecular targets and ulcerative colitis (UC)-associated transcriptional alterations remain insufficiently characterized. Methods: Candidate compounds and putative targets of Carthami Flos were identified using TCMSP and SwissTargetPrediction. Differentially expressed genes (DEGs) were identified from two independent UC transcriptomic datasets (GSE87466 and GSE75214). Predicted targets overlapping with consensus UC-associated DEGs were subjected to protein–protein interaction (PPI) network analysis, GO/KEGG enrichment, and compound–target–pathway network integration. Candidate compounds and targets were prioritized using complementary computational evidence, and sensitivity analyses were performed to assess methodological dependencies. Results: Twenty candidate compounds yielded 315 predicted targets, while transcriptomic analysis identified 774 consensus UC-associated DEGs. Their intersection revealed 32 shared genes. PPI analysis identified IL1B, MMP9, and PTGS2 as highly connected nodes. Five KEGG pathways, including IL-17 and TNF signaling, were significantly enriched under the primary transcriptomic background, although these findings were sensitive to background selection. The integrated network comprised 16 compounds, 13 targets, and five pathways. Luteolin, baicalein, and 6-hydroxynaringenin showed broad predicted target coverage, while MMP3, MMP9, PTGS2, and IDO1 emerged as candidates for further investigation. Conclusions: Integrative network pharmacology and transcriptomic analysis identified potential molecular associations between Carthami Flos and UC, particularly involving inflammation-associated signaling and extracellular matrix remodeling. These findings provide exploratory, testable hypotheses that require experimental validation. Keywords: Carthami Flos; Ulcerative colitis; Network pharmacology; Transcriptomics; Differentially expressed genes; Functional enrichment Preprint status: This manuscript is an original computational research preprint and has not been peer reviewed.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-20
DOI
https://doi.org/10.5281/zenodo.24399311
Primary Topic
Computational Drug Discovery Methods
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Integrative Network Pharmacology and Transcriptomic Analysis Identifies Candidate Targets of Carthami Flos in Ulcerative Colitis

Xiyue Duan, Siming Liu, Libing Shen
3 links
Zenodo (CERN European Organization for Nuclear Research)
Computational Drug Discovery Methods
preprint

Integrative Network Pharmacology and Transcriptomic Analysis Identifies Candidate Targets of Carthami Flos in Ulcerative Colitis

Xiyue Duan, Siming Liu, Libing Shen
preprint en

Abstract

Background: Carthami Flos contains diverse phytochemical constituents with reported biological activities, but the potential relationships between its predicted molecular targets and ulcerative colitis (UC)-associated transcriptional alterations remain insufficiently characterized. Methods: Candidate compounds and putative targets of Carthami Flos were identified using TCMSP and SwissTargetPrediction. Differentially expressed genes (DEGs) were identified from two independent UC transcriptomic datasets (GSE87466 and GSE75214). Predicted targets overlapping with consensus UC-associated DEGs were subjected to protein–protein interaction (PPI) network analysis, GO/KEGG enrichment, and compound–target–pathway network integration. Candidate compounds and targets were prioritized using complementary computational evidence, and sensitivity analyses were performed to assess methodological dependencies. Results: Twenty candidate compounds yielded 315 predicted targets, while transcriptomic analysis identified 774 consensus UC-associated DEGs. Their intersection revealed 32 shared genes. PPI analysis identified IL1B, MMP9, and PTGS2 as highly connected nodes. Five KEGG pathways, including IL-17 and TNF signaling, were significantly enriched under the primary transcriptomic background, although these findings were sensitive to background selection. The integrated network comprised 16 compounds, 13 targets, and five pathways. Luteolin, baicalein, and 6-hydroxynaringenin showed broad predicted target coverage, while MMP3, MMP9, PTGS2, and IDO1 emerged as candidates for further investigation. Conclusions: Integrative network pharmacology and transcriptomic analysis identified potential molecular associations between Carthami Flos and UC, particularly involving inflammation-associated signaling and extracellular matrix remodeling. These findings provide exploratory, testable hypotheses that require experimental validation. Keywords: Carthami Flos; Ulcerative colitis; Network pharmacology; Transcriptomics; Differentially expressed genes; Functional enrichment Preprint status: This manuscript is an original computational research preprint and has not been peer reviewed.

Zenodo (CERN European Organization for Nuclear Research)
Kunming Medical University (CN), Northeastern University (CN)
Good health and well-being
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon